SBIR/STTR Research Award

Multicolor Photoacoustic Malaria Detector

Award identifier be5c203ebf8ab4322f7ec73cfd4f153271b6e603700a66b2478f5ec0b2dad50cAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$600,000

Program and phase

STTR · Phase I

Award year

2018

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CytoAstra, LLC
Proposal award date
2018-04-01
Contract end date
2020-09-30
UEI
JZW3NTF53113
Solicitation number
PA17-303
Topic code
NIAID

Research abstract

Summary Malaria continues to be a global health prioritywith almost half of the world s populationbillionat risk and arounddeaths each yearOvertreatment is caused by lack of diagnosis and contributes to resistancea huge threat as illustrated by artemisinin resistance in Southeast AsiaLittle progress has been made in the novel methods to diagnose malarialet alone in reliably identifying asymptomatically infected individualswhich is of utmost importance for the current elimination agendaMost current malaria tests have poor sensitivity at low levels of parasitemiain routine practice it is usually well aboveorparasitesLThat high a level is insufficient to detect the large reservoir of asymptomatic individualsThe goal of this proposal is to develop an innovative multicolor malaria detector using malaria specific in vivo photoacousticPAflow cytometryPAFCplatform for the earlynoninvasiveneedle freeno blood draw and thus no contamination concernlabel freeno injection of any reagent into the bloodrapida few secondsand safeno pain or skin damagediagnosis of malariaThis technology is based on PA detection of the malaria crystalhemozoinwithin circulating infected red blood cellsRBCsdirectly in the bloodstreamTranscutaneous irradiation of hand vessels with a low pulse energy laser leads to the microscopic local heating of hemozoin accompanied by thermoacoustic generation of acoustic wavesrecorded with an ultrasound transducer attached to the skinThe high acoustic resolution and high speed multicolor PAFC can detect and identity hemozoin in deeplargehigh flow rate blood vessels to provide the earliest and fastest malaria diagnosis withinseconds at an unprecedented parasitemia threshold as low asiRBCs mLThis istimes better than existing clinical malaria testsThis goal will be achieved through two interconnected specific aimsDevelop new malaria specific PAFC diagnostic device prototypeDetermine the efficacy of PAFC devices for label free detection of iRBCs in a preclinical mouse modelThe PAFC device will not be affected by hand movement or skin pigmentationThis malaria specific PAFC technology can be used to identify asymptomatic malaria infected individuals in a short time through gentle contact of the PA probe with the intact skinThe PAFC device can be a unique tool for malaria elimination by identifying asymptomatically infected humanswhich allows targeted interventions with appropriate treatmentOverallthis method will contribute substantially to allow treatment only for those who truly are infectedwhile avoiding unnecessary and inappropriate overtreatment of other febrile illnesses PROJECT NARRATIVE Malaria continues to be a global health prioritycausingdeaths per yearReliable diagnosis is crucial to target those truly having malaria and avoid overtreatmentand consequently resistance to antimalarial drugsThis proposal aims to develop an innovative diagnostic technology for the detection of malaria parasites at an unprecedentedfold lower detection limit as compared to current testsThe method is robustnoninvasiveneedle freeno blood drawing or contamination concernlabel freeno injection of any reagents into the bloodrapida few secondseasy to useandno pain or skin damagelow costThis unmatched diagnostic performance will significantly improve appropriate treatment and importantlywill be an invaluable tool for malaria elimination allowing clinicians to identify and target low grade asymptomatically infected individuals

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

2 SBIR/STTR records share this UEI (2018–2020). Reported award amounts total $898,784. Reported amounts are not federal obligations.

Phases: Phase I

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.